Radical Cure (RC) With Tafenoquine or Primaquine After Semi-quantitative G6PD Testing: A Feasibility Study in Peru

relevant HCP working in study facilities will be trained on the relevant aspects of performing the G6PD testing, interpreting its result, evaluating patient's eligibility for RC and choosing the appropriate treatment as per their role accordingly

Refresher training on PV reporting in the selected facilities. National PV forms will be reviewed and if required, modified in consultation with the national PV system.

Supervisors in target regions will be trained as for the HCPs.

G6PD test after Malaria Vivax diagnosis

300 mg (2x150mg tablets) tafenoquine

0.5mg/kg/7 days

It will be checked if all patients have a Follow Up Visit at Day 3 \[+2 days\] after treatment start